---
figid: PMC6892276__gr4
figlink: /pmc/articles/PMC6892276/figure/f0020/
number: Fig. 4
caption: Proposed in vitro metabolic biotransformation pathway for CCT241736 in human.
  Bold arrows represent predominance of these metabolic pathways. Dotted arrows and
  asterisked enzymes represent postulated secondary metabolic pathways based on known
  metabolite structures and primary biotransformations.
pmcid: PMC6892276
papertitle: 'Metabolism of the dual FLT-3/Aurora kinase inhibitor CCT241736 in preclinical
  and human in vitro models: Implication for the choice of toxicology species.'
reftext: Francesca L. Wood, et al. Eur J Pharm Sci. 2019 Nov 1;139:104899.
pmc_ranked_result_index: '34586'
pathway_score: 0.9452913
filename: gr4.jpg
figtitle: Proposed in vitro metabolic biotransformation pathway for CCT241736 in human
year: '2019'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6892276__gr4.html
  '@type': Dataset
  description: Proposed in vitro metabolic biotransformation pathway for CCT241736
    in human. Bold arrows represent predominance of these metabolic pathways. Dotted
    arrows and asterisked enzymes represent postulated secondary metabolic pathways
    based on known metabolite structures and primary biotransformations.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CYP3A4
  - CYP2C9
  - SST241736
genes:
- word: СҮРЗА4
  symbol: CYP3A4
  source: hgnc_symbol
  hgnc_symbol: CYP3A4
  entrez: '1576'
- word: СҮРЗА4
  symbol: CYP3A4
  source: hgnc_symbol
  hgnc_symbol: CYP3A4
  entrez: '1576'
- word: СҮРЗА4
  symbol: CYP3A4
  source: hgnc_symbol
  hgnc_symbol: CYP3A4
  entrez: '1576'
- word: '*CYP2C9/2D6'
  symbol: CYP2C9
  source: hgnc_symbol
  hgnc_symbol: CYP2C9
  entrez: '1559'
chemicals:
- word: SST241736
  source: MESH
  identifier: C070440
diseases: []
---
